Search research articles
Contact Us
Filters
Showing results (441-450 of 577) with videos related to
Page
of 58
Sort By:
Clinical Pharmacokinetics
|
April 17, 2013
Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease
Ming J Poi, Craig C Hofmeister, Jeffrey S Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2014
Genetic modification of T cells redirected toward CS1 enhances eradication of myeloma cells
Jianhong Chu, Shun He, Youcai Deng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2020
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
Mehdi Hamadani, Mei-Jie Zhang, Xiao-Ying Tang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 4, 2015
Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial
Richard T Maziarz, Timothy Devos, Carlos R Bachier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 16, 2011
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303
Steven M Devine, Shelly Carter, Robert J Soiffer, et al.
Leukemia & Lymphoma
|
February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience
Filiz Yucebay, Christina Matthews, Marcin Puto, et al.
Bone Marrow Transplantation
|
April 16, 2013
Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphoma
J B Cohen, N C Hall, A S Ruppert, et al.
Plos Pathogens
|
September 5, 2025
Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversity
Xinyu Wu, Shane M Devine, Margareta Go, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 10, 2015
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphoma
Jonathon B Cohen, Amy S Ruppert, Nyla A Heerema, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 18, 2017
A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma
Joseph J Maly, Beth A Christian, Xiaohua Zhu, et al.
Page
of 58
Search research articles
Search
Showing results (441-450 of 577) with videos related to
Sort By:
Page
of 58
Clinical Pharmacokinetics
|
April 17, 2013
Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease
Ming J Poi, Craig C Hofmeister, Jeffrey S Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2014
Genetic modification of T cells redirected toward CS1 enhances eradication of myeloma cells
Jianhong Chu, Shun He, Youcai Deng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 14, 2020
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis
Mehdi Hamadani, Mei-Jie Zhang, Xiao-Ying Tang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 4, 2015
Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial
Richard T Maziarz, Timothy Devos, Carlos R Bachier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 16, 2011
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303
Steven M Devine, Shelly Carter, Robert J Soiffer, et al.
Leukemia & Lymphoma
|
February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience
Filiz Yucebay, Christina Matthews, Marcin Puto, et al.
Bone Marrow Transplantation
|
April 16, 2013
Association of pre-transplantation positron emission tomography/computed tomography and outcome in mantle cell lymphoma
J B Cohen, N C Hall, A S Ruppert, et al.
Plos Pathogens
|
September 5, 2025
Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversity
Xinyu Wu, Shane M Devine, Margareta Go, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 10, 2015
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphoma
Jonathon B Cohen, Amy S Ruppert, Nyla A Heerema, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 18, 2017
A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma
Joseph J Maly, Beth A Christian, Xiaohua Zhu, et al.
Page
of 58